Primary |
Drug Use For Unknown Indication |
43.5% |
Product Used For Unknown Indication |
13.3% |
Multiple Allergies |
9.0% |
Rhinitis Allergic |
7.2% |
Asthma |
4.2% |
Rhinitis |
4.2% |
Sinus Disorder |
3.1% |
Seasonal Allergy |
2.7% |
Nasal Congestion |
2.2% |
Sinusitis |
2.0% |
Chronic Obstructive Pulmonary Disease |
1.4% |
Hypersensitivity |
1.3% |
Ill-defined Disorder |
1.1% |
Sinus Congestion |
1.1% |
Pain |
0.9% |
Depression |
0.8% |
Nasopharyngitis |
0.6% |
Bronchitis |
0.5% |
Anxiety |
0.4% |
Chronic Sinusitis |
0.4% |
|
Drug Ineffective |
21.8% |
Epistaxis |
15.5% |
Pharmaceutical Product Complaint |
7.6% |
Headache |
7.1% |
Anosmia |
5.8% |
Nasal Discomfort |
4.5% |
Death |
4.0% |
Product Quality Issue |
3.7% |
Sneezing |
3.7% |
Rhinorrhoea |
3.2% |
Sinusitis |
3.2% |
Cataract |
2.6% |
Vision Blurred |
2.6% |
Parosmia |
2.3% |
Rash |
2.3% |
Nasal Dryness |
2.1% |
Sinus Disorder |
2.1% |
Nasal Congestion |
1.9% |
Therapeutic Response Unexpected |
1.9% |
Nausea |
1.8% |
|
Secondary |
Product Used For Unknown Indication |
18.2% |
Asthma |
15.9% |
Drug Use For Unknown Indication |
14.3% |
Hypersensitivity |
6.8% |
Sinusitis |
6.3% |
Gastrooesophageal Reflux Disease |
4.0% |
Chronic Obstructive Pulmonary Disease |
3.5% |
Diabetes Mellitus |
3.5% |
Depression |
2.9% |
Hypertension |
2.9% |
Sinus Congestion |
2.9% |
Multiple Allergies |
2.6% |
Chest Pain |
2.4% |
Bronchitis |
2.3% |
Migraine |
2.3% |
Anxiety |
1.9% |
Muscle Spasms |
1.9% |
Diabetic Neuropathy |
1.8% |
Rhinitis Allergic |
1.8% |
Arthralgia |
1.7% |
|
Memory Impairment |
13.4% |
Drug Ineffective |
10.2% |
Pyrexia |
9.4% |
Tendon Rupture |
5.5% |
Vomiting |
5.5% |
Myocardial Infarction |
4.7% |
Sinusitis |
4.7% |
Wheezing |
4.7% |
Death |
3.9% |
Drug Hypersensitivity |
3.9% |
Epistaxis |
3.9% |
Pain |
3.9% |
Throat Irritation |
3.9% |
Adverse Event |
3.1% |
Asthma |
3.1% |
Medication Error |
3.1% |
Palpitations |
3.1% |
Panic Attack |
3.1% |
Pharmaceutical Product Complaint |
3.1% |
Pneumonia |
3.1% |
|
Concomitant |
Product Used For Unknown Indication |
29.7% |
Drug Use For Unknown Indication |
15.3% |
Asthma |
10.1% |
Hypersensitivity |
5.6% |
Hypertension |
5.6% |
Pain |
4.7% |
Depression |
3.3% |
Gastrooesophageal Reflux Disease |
3.1% |
Rheumatoid Arthritis |
3.0% |
Chronic Obstructive Pulmonary Disease |
2.7% |
Osteoporosis |
2.3% |
Anxiety |
2.1% |
Seasonal Allergy |
1.8% |
Blood Cholesterol Increased |
1.8% |
Multiple Allergies |
1.7% |
Diabetes Mellitus |
1.7% |
Contraception |
1.4% |
Insomnia |
1.4% |
Crohn's Disease |
1.4% |
Arthritis |
1.4% |
|
Vomiting |
14.1% |
Weight Decreased |
9.3% |
Weight Increased |
9.2% |
Pain |
6.0% |
Pulmonary Embolism |
5.6% |
Drug Ineffective |
5.1% |
Pneumonia |
4.7% |
Wheezing |
4.5% |
Urticaria |
4.5% |
Nausea |
4.3% |
Dyspnoea |
3.8% |
Rash |
3.6% |
Sinusitis |
3.6% |
Myocardial Infarction |
3.3% |
Tremor |
3.3% |
Headache |
3.2% |
Vision Blurred |
3.1% |
Urinary Tract Infection |
3.0% |
Pruritus |
3.0% |
Death |
2.9% |
|
Interacting |
Product Used For Unknown Indication |
62.2% |
Drug Use For Unknown Indication |
21.6% |
Oropharyngeal Pain |
5.4% |
Tongue Ulceration |
5.4% |
Laryngitis |
2.7% |
Plasma Cell Myeloma |
2.7% |
|
Loss Of Consciousness |
50.0% |
Drug Interaction |
25.0% |
Skin Exfoliation |
25.0% |
|